Lumicell Diagnostics, a Waltham, MA-based developer of a device enabling doctors to check tumor sites for remaining cancer cells after surgeries, has brought in $2.7 million in equity-based funding, an SEC filing shows. Waltham-based Kodiak Venture Partners lists Lumicell as one of its portfolio companies on its website. The new funding comes from four investors, … Continue reading “Lumicell Takes in $2.7M”
Category: Boston
NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders
NeuroHealing Pharmaceuticals was founded in 2004 with an unusual mission and out-of-the-box business model. It scours the vast world of approved drugs for molecules that can be reformulated and then repositioned as therapies to treat diseases of the central nervous system. And it does so with only four full-time employees, because NeuroHealing is a “virtual” … Continue reading “NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders”
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend
Infinity Pharmaceuticals’ top execs sometimes get strange looks when they say they are developing a new drug for pancreatic cancer. This, after all, is a wicked malignancy that usually kills patients in just a few months, and has dashed the hopes of many cancer drug developers over the years. Yet Cambridge, MA-based Infinity (NASDAQ: [[ticker:INFI]]) … Continue reading “Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend”
An Investor’s Observations on Investing and Company Building in an Emerging Market: India
As a technology venture capitalist, I provide funds to help companies reach their next evolutionary level more quickly, efficiently, and successfully than without my cash. My mandate is to also offer non-cash benefit and support that, one might argue, is even more critical than cash to speed ahead of milestones, competitors, and expectations. In the … Continue reading “An Investor’s Observations on Investing and Company Building in an Emerging Market: India”
Lumicell Diagnostics Garners $2,708,236 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=60c1cbc7-c775-49c0-9c72-6f795ab5b8fd&Preview=1 Date 6/2/2011 Company Name Lumicell Diagnostics Mailing Address 1000 Winter St. Waltham, MA 02451 Company Description The company is developing a medical device that can detect remaining cancer cells after surgery. Website Undisclosed Transaction Type Venture Equity Transaction Amount $2,708,236 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC … Continue reading “Lumicell Diagnostics Garners $2,708,236 New Funding”
Sun Catalytix Hires New CEO, Formerly of LumenZ
Sun Catalytix, a Cambridge, MA-based energy storage and renewable fuels startup, said today it has added Mike Decelle as its new president and chief executive. Decelle is a photonics industry veteran who was mostly recently CEO of LumenZ, a Boston-based LED technology company that was reported by the Boston Globe to be shut down earlier … Continue reading “Sun Catalytix Hires New CEO, Formerly of LumenZ”
With California Deals Heating Up, Polaris Venture Partners to Open Palo Alto Office
Polaris Venture Partners is significantly increasing its presence in California, where roughly one-third of its active portfolio companies are now based, and plans to soon open an office in Palo Alto, in the heart of Silicon Valley, Xconomy has learned. Polaris general partner Dave Barrett says the firm is still looking at space and so … Continue reading “With California Deals Heating Up, Polaris Venture Partners to Open Palo Alto Office”
Today’s XSITEing Opportunity: Galaxy Tab 10.1 Giveaway
As if there weren’t already enough reasons to be looking forward to the June 16 Xconomy Summit on Innovation, Technology, and Entrepreneurship, today we’re adding a thin, shiny reason with HD video and front and rear cameras. We’re going to throw the names of the first 50 folks to register in June for XSITE 2011 into … Continue reading “Today’s XSITEing Opportunity: Galaxy Tab 10.1 Giveaway”
HBA Boston Women in Science- New Paradigms in Drug Development: Transforming Innovation
This Healthcare Businesswomen’s Association event at Genzyme will feature the program director of MIT’s New Drug Development Paradigms initiative.He’ll lead a panel of those representing the academia, regulatory, patient, and industry groups with a stake in the drug development process. Register here.
Ziptr Snaps Up $6.8M
Burlington, MA-based software startup Ziptr has brought in $6.8 million in equity financing from 26 investors, an SEC filing shows. Ziptr’s website says that its software, which is in its beta version, is focused on privacy and compliance for businesses. Last October the company raised $1.5 million in a debt financing from 25 investors.
Dossia Partners With Health Language To Offer Electronic Medical Records in Plain English
The non-profit consortium Dossia has branded itself as a provider of digital health records focused on ease of use for the consumer. The organization got started in 2006 to offer the Web-based records to employees at its member companies—like BP America, Intel, Pitney Bowes, and Wal-Mart—and has racked up plenty of data on patients’ doctors … Continue reading “Dossia Partners With Health Language To Offer Electronic Medical Records in Plain English”
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News
Boston tech and life sciences companies kept busy even through the holiday weekend with partnership, IPO, and financing news. —Proteostasis Therapeutics of Cambridge, MA, received an initial payment of $20 million from Elan to develop traditional small molecule drugs and diagnostics against neurodegenerative diseases like Parkinson’s, Huntington’s, and multiple sclerosis. The partnership could also include … Continue reading “Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News”
SensAble Receives $2,662,517 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=96b74cb2-8e0d-4c56-84d6-2c236086b2a7&Preview=1 Date 6/1/2011 Company Name SensAble Mailing Address 15 Constitution Way Woburn, MA 01801 Company Description Founded in 1993, SensAble Technologies is a leading developer of 3D touch-enabled (force feedback) solutions and technology that allow users to not only see and hear an on-screen computer application, but to actually ‘feel’ it. The … Continue reading “SensAble Receives $2,662,517 New Funding Round”
Ziptr Receives $6,837,806 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aa5265af-0cfa-4292-ba67-31931b362b0e&Preview=1 Date 6/1/2011 Company Name Ziptr Mailing Address 128 Wheeler Rd. Burlington, MA 01803 Company Description The company is developing a service to replace multiple passwords and accounts with a single secure digital repository and secure messaging service. Website http://www.Ziptr.com Transaction Type Venture Equity Transaction Amount $6,837,806 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Ziptr Receives $6,837,806 New Financing Round”
Massachusetts Life Sciences Innovation Day 2011
The fourth annual Massachusetts Life Sciences Innovation Day is build around the theme of “Building Biotech Backward”—looking at the issues a successful company could face in 10 years and exploring how that could influence its ideas today. It aims to draw academics, entrepreneurs, and investors in life sciences, so register here to be part of the … Continue reading “Massachusetts Life Sciences Innovation Day 2011”
Myriant Technologies Files for $125M IPO
Myriant Technologies, a Quincy, MA-based developer of biochemicals, revealed its intention to raise $125 million in an initial public offering, according to documents filed with the SEC. The company plans to put the proceeds toward completing a plant in Louisiana, as well as working capital, research and development, and general corporate purposes. It reported a … Continue reading “Myriant Technologies Files for $125M IPO”
Novophage Nets $5.7M from Flybridge, Others
Boston-based Novophage has raised $5.7 million in a Series A financing round led by Flybridge Capital Partners. Founder Collective, Boston University, and strategic investors Chevron Technology Ventures and The Kraft Group also participated in the round. The news was first reported by Scott Kirsner of the Boston Globe. Novophage engineers viruses (phages) to combat bacterial … Continue reading “Novophage Nets $5.7M from Flybridge, Others”
Calling All Startups: We Want You to Speak at XSITE on June 16 (If You Are The One)
OK, let’s cut to the chase here. We’re looking for The One. One more cool, young startup that could change the world. We’ve got 11 confirmed. We want an even dozen. Do you have what it takes? The setting: It’s our third annual flagship conference, XSITE, at Babson College on June 16, and the startup … Continue reading “Calling All Startups: We Want You to Speak at XSITE on June 16 (If You Are The One)”
Aveo Forms $15 Million Cancer Deal With J&J Unit
Cambridge-based Aveo Pharmaceuticals (NASDAQ: [[ticker:AVEO]]) has entered into a licensing deal with Centocor Ortho Biotech, a unit of Johnson & Johnson (NYSE: [[ticker:JNJ]]), according to a press release. The two companies will work together on Aveo’s antibodies targeting the RON (Recepteur d’Origine Nantais) receptor, which may be involved in regulation of tumor growth, cancer survival and … Continue reading “Aveo Forms $15 Million Cancer Deal With J&J Unit”
Excelimmune Nabs $10.5M Series B Deal
Excelimmune, a Woburn, MA-based developer of a human recombinant polyclonal antibody-based drugs, announced today that it had wrapped up a $10.5 million Series B financing, from new and previous high net worth individual backers. The money will go to enhancing Excelimmune’s discovery platform and manufacturing processes, and toward development of Staphguard, the company’s treatment for Staph … Continue reading “Excelimmune Nabs $10.5M Series B Deal”
Grubwithus Hits Boston On Its Quest To Bring Group Meals for Strangers to 30 Cities This Year
Seventh in a series of profiles of Y Combinator Winter 2011 startups. Grubwithus, a group-buying-meets-online-dating startup out of Y Combinator, is hitting Boston this week. The startup is introducing its group meals for strangers service in the city on June 1st. Similar to Groupon, Chicago-based Grubwithus works with restaurants to offer its users discounted meals. Unlike … Continue reading “Grubwithus Hits Boston On Its Quest To Bring Group Meals for Strangers to 30 Cities This Year”
Ariad Eagerly Awaits the Big Show, ASCO, To Display Cancer Trial Results
Ariad Pharmaceuticals’ stock has surged 73 percent since New Year’s Day, so you could say CEO Harvey Berger is having a better-than-average year. The Cambridge, MA-based cancer drug developer has seen its market valuation eclipse $1 billion, on a wave of anticipation heading into what could be the most important medical meeting in his company’s … Continue reading “Ariad Eagerly Awaits the Big Show, ASCO, To Display Cancer Trial Results”
Excelimmune Secures $5,000,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a52a0438-c09e-4da3-a269-01bcfb305c9f&Preview=1 Date 5/31/2011 Company Name Excelimmune Mailing Address 12-B Cabot Road Woburn, MA 01801 Company Description Excelimmune Inc., based in Cambridge, is a biotechnology company developing therapuetic applications of human recombinant polyclonal antibodies. Website http://www.excelimmune.com Transaction Type Venture Equity Transaction Amount $5,000,000 Transaction Round Series B Proceeds Purposes In addition to doubling … Continue reading “Excelimmune Secures $5,000,000 Series B Financing”
Novophage Garners $5,750,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=77beeb4c-fadf-4f9e-a167-04de286664ca&Preview=1 Date 5/31/2011 Company Name Novophage Mailing Address Undisclosed Cambridge, MA 02140 Company Description Novophage is developing a first-in-class anti-biofilm solution that is green and highly effective against biofilms. Website http://www.novophage.com Transaction Type Venture Equity Transaction Amount $5,750,000 Transaction Round Series A Proceeds Purposes The company will use the money to continue … Continue reading “Novophage Garners $5,750,000 Series A Funding Round”
Creating Breakthrough – In Your Organization and Yourself
This event aims to help attendees identify breakthrough opportunities for their companies. Entrepreneurs will get help targeting challenges and figuring out ways to grow. Register here.
Founder Dialogues V
Acme Packet president and CEO Andy Ory will chat with Founder Collective’s Eric Paley at this fifth installment of Founder Dialogues. Come hear Ory dish on his ideas, challenges, and advice to budding entrepreneurs. Register here.
Enterprise 2.0 Boston
This conference will explore the latest in collaboration technology. Panels and workshops will cover topics such as analytics, mobile, compliance, internal communications, social apps, and more. Register here.
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News
This week was full with news of progress from New England drug developers. —Waltham, MA-based antibody drug maker ImmunoGen (NASDAQ: [[ticker:IMGN]]) sold 7 million shares of stock at $12 apiece. The company had $115.8 million in cash on hand at the end of March, a quarterly report showed. —Biogen Idec (NASDAQ: [[ticker:BIIB]]) of Weston, MA, … Continue reading “Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News”
Yes, Technology Is Taking Jobs Away, But Here’s How It Might Give Them Back
Back in March, I wrote a column arguing that smartphones, tablet computers, Internet TVs and other personal technologies are delivering an unexpected bonus. Rather than depreciating, the way most equipment does, these gadgets actually get more valuable over time thanks to the hundreds of new apps that debut every week, plus free upgrades for existing … Continue reading “Yes, Technology Is Taking Jobs Away, But Here’s How It Might Give Them Back”
HistoRx Receives $2,605,245 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=606cea67-aa12-4186-86d2-4635027659bb&Preview=1 Date 5/27/2011 Company Name HistoRx Mailing Address 300 George Street New Haven, CT 06511 Company Description HistoRx has commercialized a technology originally developed at Yale Medical School used in the development of targeted drug therapies which are driving the evolution of personalized medicine. The Company’s new generation of predictive companion diagnostic … Continue reading “HistoRx Receives $2,605,245 New Round”
MedVentive Obtains $1,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=765b9327-ca46-4ca2-87c0-510718ae71f6&Preview=1 Date 5/27/2011 Company Name MedVentive Mailing Address 400 Fifth Avenue Waltham, MA 02451 Company Description MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Website … Continue reading “MedVentive Obtains $1,500,000 New Funding Round”
Spreadshirt Promotes CMO Rooke To CEO
Spreadshirt, a customized clothing e-commerce company with U.S. headquarters in Boston, announced it has promoted its chief marketing officer Philip Rooke to the role of CEO. Rooke has held previous ecommerce positions at iVillage UK, Tesco.com, and Skinstore, and will help lead Spreadshirt in growth through its product customization and print on demand businesses. Previous … Continue reading “Spreadshirt Promotes CMO Rooke To CEO”
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence
When Cambridge, MA-based Alnylam (NASDAQ: [[ticker:ALNY]]) made its debut last year at the annual American Society of Clinical Oncology (ASCO) conference, it only had a pittance of safety data on its drug, which is designed to treat advanced solid tumors that have spread to the liver. At this year’s conference, which starts June 3 in Chicago, … Continue reading “Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence”
Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters
We are getting more and more excited about XSITE 2011—the Xconomy Summit on Innovation, Technology, and Entrepreneurship, our annual full-day innovation conference set to take place on June 16 at Babson College. We began announcing keynoters and other featured speakers several weeks ago, and the list has been building—to more than 40 speakers. They run … Continue reading “Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters”
Ford Lists Top 25 EV Cities, Highlights Pacific Coast Corridor for Future EV Road Trips
With the average price of gasoline reaching almost $4 a gallon nationwide, it’s safe to say a lot of people are curious about the all-electric vehicles (EV) that many automakers have been showing off lately. Still, it’s hard to justify the $100,000-plus sticker price for a Tesla Roadster or the $33,000 price of a Nissan … Continue reading “Ford Lists Top 25 EV Cities, Highlights Pacific Coast Corridor for Future EV Road Trips”
Look Out, Mean Girls and Slackers: Objective Logistics Tracks Work Habits in Restaurants to Boost Sales
Slackers hate it. Go-getters love it. And store owners and managers? Well, so far they seem to be buying it. I’m talking about Objective Logistics, a New Bedford, MA-based software startup that’s looking to transform work environments, starting with restaurants and retail stores. “It’s polarizing as hell,” says CEO and co-founder Phil Beauregard. If you … Continue reading “Look Out, Mean Girls and Slackers: Objective Logistics Tracks Work Habits in Restaurants to Boost Sales”
inStream Media Receives $1,379,170 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=29aaefe2-c363-4420-9207-7dcd03f97abd&Preview=1 Date 5/26/2011 Company Name inStream Media Mailing Address 275 Grove Street Newton, MA 02466 Company Description Every day there are millions of shoppers connected by where and when they shop, what they are buying, and what they use to pay.inStream’s patent pending marketing solution allows brands to harness the power of … Continue reading “inStream Media Receives $1,379,170 New Round”
NanoComp Technologies Lands $281,469 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=054610e3-4c9a-4325-8f88-9a055738f63f&Preview=1 Date 5/26/2011 Company Name NanoComp Technologies Mailing Address 162 Pembroke Road Concord, NH 03301 Company Description NanoComp Technologies Inc (NCTI) was formed in 2004 as a spin-out of Synergy Innovations, Inc. a Concord, NH based technology development company. NCTI’s purpose is to leverage its proprietary and fundamental advancements in the production … Continue reading “NanoComp Technologies Lands $281,469 New Funding”
Improving Health While Lowering Cost: Come Hear About the Grand Challenge of Healthtech at XSITE on June 16
Most days, I report and write about traditional things people would consider healthcare innovations with big business potential—new drugs, devices, and diagnostics. Most of these things end up adding costs to the healthcare system. But given the ever-rising costs of healthcare in the U.S., more and more entrepreneurial energy is being channeled in other ways … Continue reading “Improving Health While Lowering Cost: Come Hear About the Grand Challenge of Healthtech at XSITE on June 16”
AutoVirt Adds $5M
AutoVirt, a Nashua, NH-based file virtualization software maker, has brought in $5 million in new equity funding from five investors, according to a filing with the SEC. In October, the company raised $3.8 million from four investors, and last June it took in $1.5 million in a debt and rights offering.
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs
Cambridge, MA-based Proteostasis Therapeutics has found a big new benefactor to support its R&D against neurological diseases. Proteostasis said today it has formed a strategic alliance with Ireland-based Elan to develop traditional small molecule drugs and diagnostics with Proteostasis against neurodegenerative diseases like Parkinson’s, Huntington’s, and multiple sclerosis. Elan, the developer of the hit multiple … Continue reading “Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs”
TenMarks, Education Software Startup, Looks to Improve Kids’ Math Skills as Summer Beckons
You wouldn’t know it from the weather until yesterday, but summer is on its way. Soon classes will be out of session and students of all ages will be running wild. What that means, besides more Commencement speeches (and, soon, being able to get a seat at a Harvard or Davis Square café), is that … Continue reading “TenMarks, Education Software Startup, Looks to Improve Kids’ Math Skills as Summer Beckons”
ImmunoGen Raises $84M, Cablevision Founder Backs Crimson Hexagon, BzzAgent Bought, & More Boston-Area Deals News
New England IT and life sciences startups warmed up this week with financing and acquisition news. —Andover, MA-based SiGe Semiconductor scrapped its plans to go public and was instead acquired by Skyworks Solutions (NASDAQ: [[ticker:SWKS]]) of Woburn, MA, for $210 million upfront and potentially $65 million more tied to certain milestones. —Nashua, NH-based VGo Communications, … Continue reading “ImmunoGen Raises $84M, Cablevision Founder Backs Crimson Hexagon, BzzAgent Bought, & More Boston-Area Deals News”
QD Vision, Crimson Hexagon, and Other Boston Startup Financings Fit Trend Across Industries
Busy day for company financings, as everyone gets ready for the holiday weekend (and unofficial start of summer). It’s worth noting the step up in dollar amounts as you go from Internet software and social media ($5M), to nanotech/materials ($22M), to cleantech and energy ($57M), to biotech/pharma and life sciences ($91M). Yes, biotech and energy … Continue reading “QD Vision, Crimson Hexagon, and Other Boston Startup Financings Fit Trend Across Industries”
Casenet Raises $3.3M More
Bedford, MA-based healthcare software company Casenet has added $3.3 million in equity financing, and has increased the size of its funding round to hit as much as $15.8 milion, an amended SEC filing shows. The company has brought this money in atop of $8.4 million in equity financing that it raised out of a $8.8 … Continue reading “Casenet Raises $3.3M More”
$6M More for Harvest Power
Waltham, MA-based Harvest Power, a cleantech and waste management startup with operations in Seattle and Vancouver, BC, said today it has raised $6 million from new investor SAM Private Equity, based in Zurich. The deal is an extension of Harvest’s Series B round, first announced in March, which now totals $57.7 million. The company was … Continue reading “$6M More for Harvest Power”
Desh Deshpande’s XSITE Keynote: Making an Impact Through Entrepreneurship Driven by Technological and Social Innovation
It is less than a month until XSITE 2011—the Xconomy Summit on Innovation, Technology, and Entrepreneurship, our annual full-day innovation extravaganza that will take place this year on June 16 at Babson College. We have already announced most of the keynoters and many other speakers, which you can find here, along with the registration information. … Continue reading “Desh Deshpande’s XSITE Keynote: Making an Impact Through Entrepreneurship Driven by Technological and Social Innovation”
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing
Today marks a major milestone in Cambridge, MA-based Radius Health’s long quest to enter the multibillion-dollar osteoporosis market. The company announced that it has raised $91 million in a third financing round, which includes $66 million in equity. What’s more, upon the closing of the financing, Radius merged with an unlisted shell company (“MAC”), so … Continue reading “Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing”
Debit Cards Aren’t For Stupid People: Q&A with PerkStreet CEO on Flying Into the Startup Abyss
Dan O’Malley created a Web-based financial services company in 2008. Crazy, to put it in his words, since the financial markets were in meltdown mode. Now his startup, PerkStreet Financial, says it has more customers than half the banks and credit unions in the country each do. Boston-based PerkStreet has gotten plenty of buzz for … Continue reading “Debit Cards Aren’t For Stupid People: Q&A with PerkStreet CEO on Flying Into the Startup Abyss”
Building a Company That Stands for Something: A Video Interview With David Hauser
I had the pleasure of sitting down with David Hauser recently to talk about his Boston-area company, the Grasshopper Group. David is the CTO of the company and co-founded it with Siamak Taghaddos in 2003 when they were both students at Babson College. From its beginnings as a virtual phone system, the Grasshopper Group is now … Continue reading “Building a Company That Stands for Something: A Video Interview With David Hauser”